Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-11-05
1994-06-21
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142248, 5142252, 5142262, 544 53, 544 54, 544 55, 546118, A61K 3144, C07D47104
Patent
active
053228472
ABSTRACT:
A series of imidazo[4,5-c]pyridines which inhibit platelet activating factor (PAF) and also block leukotriene D4 receptors are useful in treating asthma, arthritis, psoriasis, gastrointestinal distress, myocardial infarction, stroke and shock.
REFERENCES:
patent: 4661596 (1987-04-01), Kreft, III et al.
patent: 4904671 (1990-02-01), Cooper
Cooper Kelvin
Eggler James F.
Fray Michael J.
Marfat Anthony
Benson Gregg C.
Gupta Y. N.
Pfizer Inc.
Richardson Peter C.
Ronau Robert T.
LandOfFree
Azabenzimidazoles in the treatment of asthma, arthritis and rela does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azabenzimidazoles in the treatment of asthma, arthritis and rela, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabenzimidazoles in the treatment of asthma, arthritis and rela will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2220801